Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells

✍ Scribed by Gordon N. Gill; Janice E. Buss; Cheri S. Lazar; Aliza Lifshitz; Jonathan A. Cooper

• Publisher: John Wiley and Sons
• Year: 1982
• Tongue: English
• Weight: 532 KB
• Volume: 19
• Category: Article
• ISSN: 0730-2312
• DOI: 10.1002/jcb.240190306

✦ Synopsis

Abstract

Epidermal growth factor (EGF), which stimulates tyrosine‐specific protein kinase activity both in vivo and in vitro, inhibits proliferation of A431 human epidermoid carcinoma cells. After mutagenesis clonal cell lines that were resistant to the growth inhibitory effects of EGF were selected. All six variants examined contained decreased EGF‐stimulated protein kinase. The number of EGF receptors in variant cells decreased in parallel with EGF‐stimulated protein kinase activity so that the specific activity of EGF‐stimulated protein kinase per EGF receptor remained constant in variant cell lines with up to tenfold reductions in both activities. This result suggests that both EGF‐ binding and kinase activities reside in the same or closely coupled molecules. The effect of EGF on growth of two resistant variants was examined in detail. Clone 29 contains ∼50% and clone 4 contains ∼20% of the EGF‐stimulated protein kinase activity of the parental A431 cell line. In serum‐supplemented medium, EGF stimulated proliferation of clone 29 but did not affect growth of clone 4. In a l:1 mixture of DME and F‐12 medium without scrum, EGF caused both clone 29 and clone 4 to grow as well as in 10% serum. These variants, which were selected for resistance to the growth inhibitory effects of EGF, thus exhibit a strong mitogenic response to EGF. This result suggests that resistance to the growth inhibitory effect of EGF may involve both a decrease in EGF‐stimulated protein kinase and an alteration in the response pathway.